| Lauren Dandurand, AGACNP-BC | |
|
200 E 89th Ave Ste 2a, Merrillville, IN 46410-7319 | |
| (219) 736-2800 | |
| Not Available |
| Full Name | Lauren Dandurand |
|---|---|
| Gender | Female |
| Speciality | Family Medicine - Geriatric Medicine |
| Location | 200 E 89th Ave Ste 2a, Merrillville, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295322642 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | 71010539A (Indiana) | Primary |
| Entity Name | Suniti Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285667550 PECOS PAC ID: 1759413172 Enrollment ID: O20100721000487 |
News Archive
This study demonstrates that patients' relative preference for medication versus psychotherapy should be considered when offering a treatment to depressed patients because receiving the preferred treatment conveys an additional and clinically relevant benefit in outcome.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.
Four tiny segments of RNA appear to play critical roles in controlling cholesterol and triglyceride metabolism. In their report receiving advance online publication in Nature Medicine, a Massachusetts General Hospital-based research team describes finding how these microRNAs could reduce the expression of proteins playing key roles in the generation of beneficial HDL cholesterol, the disposal of artery-clogging LDL cholesterol, control of triglyceride levels and other risk factors of cardiovascular disease.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for SAPHRIS (asenapine) sublingual tablets in the acute treatment of schizophrenia in adults and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Dandurand, AGACNP-BC 200 E 89th Ave Ste 2a, Merrillville, IN 46410-7319 Ph: (219) 736-2800 | Lauren Dandurand, AGACNP-BC 200 E 89th Ave Ste 2a, Merrillville, IN 46410-7319 Ph: (219) 736-2800 |
News Archive
This study demonstrates that patients' relative preference for medication versus psychotherapy should be considered when offering a treatment to depressed patients because receiving the preferred treatment conveys an additional and clinically relevant benefit in outcome.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.
Four tiny segments of RNA appear to play critical roles in controlling cholesterol and triglyceride metabolism. In their report receiving advance online publication in Nature Medicine, a Massachusetts General Hospital-based research team describes finding how these microRNAs could reduce the expression of proteins playing key roles in the generation of beneficial HDL cholesterol, the disposal of artery-clogging LDL cholesterol, control of triglyceride levels and other risk factors of cardiovascular disease.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for SAPHRIS (asenapine) sublingual tablets in the acute treatment of schizophrenia in adults and in the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy.
› Verified 3 days ago
Johann David Farley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8300 Broadway Ste D2, Merrillville, IN 46410 Phone: 219-649-0044 Fax: 219-649-0055 | |
Dr. Brian H Weiss, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 West 80th Ave., Ste A, Merrillville, IN 46410 Phone: 219-791-9785 Fax: 219-791-9787 | |
Dr. Oranu G Ibekie, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1574 E 85th Ave, Merrillville, IN 46410 Phone: 219-769-4400 Fax: 219-795-1419 | |
Dr. Syed S Kazmi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 616 W 81st Ave, Merrillville, IN 46410 Phone: 312-421-1016 | |
Fadi I Alzeidan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7863 Broadway, Merrillville, IN 46410 Phone: 219-769-6639 Fax: 219-769-0636 | |
Jessica Jean Glinski, DNP, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 5043 E 81st Ave, Merrillville, IN 46410 Phone: 219-707-5276 |